Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar 7;12(3):524-535.
doi: 10.2215/CJN.06180616. Epub 2016 Nov 28.

Recognition and Management of Resistant Hypertension

Branko Braam  1 , Sandra J Taler, Mahboob Rahman, Jennifer A Fillaus, Barbara A Greco, John P Forman, Efrain Reisin, Debbie L Cohen, Mohammad G Saklayen, S Susan Hedayati
Affiliations
Review

Recognition and Management of Resistant Hypertension

Branko Braam et al. Clin J Am Soc Nephrol. .

Abstract

Despite improvements in hypertension awareness and treatment, 30%-60% of hypertensive patients do not achieve BP targets and subsequently remain at risk for target organ damage. This therapeutic gap is particularly important to nephrologists, who frequently encounter treatment-resistant hypertension in patients with CKD. Data are limited on how best to treat patients with CKD and resistant hypertension, because patients with CKD have historically been excluded from hypertension treatment trials. First, we propose a consistent definition of resistant hypertension as BP levels confirmed by both in-office and out-of-office measurements that exceed appropriate targets while the patient is receiving treatment with at least three antihypertensive medications, including a diuretic, at dosages optimized to provide maximum benefit in the absence of intolerable side effects. Second, we recommend that each patient undergo a standardized, stepwise evaluation to assess adherence to dietary and lifestyle modifications and antihypertensive medications to identify and reduce barriers and discontinue use of substances that may exacerbate hypertension. Patients in whom there is high clinical suspicion should be evaluated for potential secondary causes of hypertension. Evidence-based management of resistant hypertension is discussed with special considerations of the differences in approach to patients with and without CKD, including the specific roles of diuretics and mineralocorticoid receptor antagonists and the current place of emerging therapies, such as renal denervation and baroreceptor stimulation. We endorse use of such a systematic approach to improve recognition and care for this vulnerable patient group that is at high risk for future kidney and cardiovascular events.

Keywords: Antagonists; Antihypertensive Agents; Denervation; Humans; Life Style; Mineralocorticoid Receptor; Pressoreceptors; Renal Insufficiency, Chronic; blood pressure; cardiovascular disease; chronic kidney disease; diuretics; hypertension; kidney; renal denvervation; sodium intake.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A systematic approach to the patient with suspected resistant hypertension.
See this image and copyright information in PMC

References

    1. Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC: Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 124: 1046–1058, 2011 - PMC - PubMed
    1. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, Tremblay MS, Walker R, Johansen H, Campbell N: Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 183: 1007–1013, 2011 - PMC - PubMed
    1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM; American Heart Association Professional Education Committee : Resistant hypertension: Diagnosis, evaluation, and treatment:A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117: e510–e526, 2008 - PubMed
    1. Weitzman D, Chodick G, Shalev V, Grossman C, Grossman E: Prevalence and factors associated with resistant hypertension in a large health maintenance organization in Israel. Hypertension 64: 501–507, 2014 - PubMed
    1. Gifford RW, Jr.: Resistant hypertension. Introduction and definitions. Hypertension 11: II65–II66, 1988 - PubMed

MeSH terms

Substances

Supplementary concepts